Join Our Technical and Poster Sessions at Bioprocessing Summit Europe
Discover how Bio-Rad’s process chromatography solutions can help accelerate method and process development for biopharmaceutical manufacturing. Explore innovative approaches, gain practical insights, and connect with experts to optimize your workflows.
March 10-12
Barcelona, Spain
Optimizing Antibody-Drug Conjugate Purity with Mixed-Mode Chromatography
Tuesday
9:30 AM CET
Antibody–drug conjugates (ADCs) combine targeted antibodies with cytotoxic drugs, making purity essential. Artur Stanczak presents a case study on mixed-mode chromatography solutions for purifying an emtansine biosimilar ADC, removing aggregates and enriching DAR. The study shows how mixed-mode chromatography offers a scalable and reproducible solution for improving product quality and consistency in both biosimilar and novel ADC manufacturing.
Speaker
Artur Stanczak, MS
Field Application Specialist, Process Chromatography
Bio-Rad Laboratories, Inc.
Poster Session
- Enhancing purity of an emtansine biosimilar ADC through mixed-mode chromatography
- Improving large biomolecule purification through DOE studies and advanced resin technologies
- Evaluating viral clearance in mAb purification using a weak AEX-HIC chromatography resin